Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors

Clinical trial NCT06617169 · RECRUITING

Trial details

NCT number: NCT06617169
Sponsor: Monopar Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult Bladder Cancer Urothelial Carcinoma Triple-negative Breast Cancer Lung Cancer Colorectal Cancer Gastric Cancer Ovarian Cancer Pancreatic Cancer

Start date: 2024-10-08
Primary completion: 2026-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.